Development Level

Tbio 3 | 10,625
Tchem 2 | 1,890

Disease

osteosarcoma 5 | 7,933
Cancer 4 | 2,346
Cockayne syndrome 4 | 54
Xeroderma pigmentosum 4 | 41
Photosensitive trichothiodystrophy 3 | 24
intraductal papillary-mucinous carcinoma (IPMC) 3 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 3 | 3,289
lung cancer 3 | 4,466
medulloblastoma, large-cell 3 | 6,234
ovarian cancer 3 | 8,484
Arsenic Poisoning 2 | 59
Breast cancer 2 | 3,094
CAMFAK syndrome 2 | 4
Cerebrooculofacioskeletal Syndrome 1 2 | 4
Fanconi's anemia 2 | 50
Neoplasm Metastasis 2 | 138
Neoplasms, Germ Cell and Embryonal 2 | 13
Pena Shokeir syndrome Type 2 2 | 4
Peripheral Neuropathy 2 | 303
Testicular Neoplasms 2 | 5
nasopharyngeal carcinoma 2 | 1,056
psoriasis 2 | 6,685
APRT deficiency, Japanese type 1 | 1
Adenine phosphoribosyltransferase deficiency 1 | 6
Adenocarcinoma of lung (disorder) 1 | 48
Aplastic anemia 1 | 18
Ataxia with oculomotor apraxia type 1 1 | 5
Bladder Neoplasm 1 | 109
CEREBROOCULOFACIOSKELETAL SYNDROME 4 1 | 1
Carcinoma 1 | 2,147
Cataract 1 | 104
Chromosome Aberrations 1 | 15
Cockayne Syndrome, Type I 1 | 3
Cockayne Syndrome, Type II 1 | 3
Colorectal Neoplasms 1 | 217
Crohn's disease 1 | 304
Endometriosis 1 | 535
FANCONI ANEMIA, COMPLEMENTATION GROUP Q 1 | 1
Fanconi Anemia 1 | 19
Lesch-Nyhan syndrome 1 | 12
Mammary Neoplasms 1 | 410
Melanoma 1 | 261
Micronuclei, Chromosome-Defective 1 | 19
Nephrolithiasis 1 | 30
Neutropenia 1 | 78
Primary hyperoxaluria 1 | 15
Progeria 1 | 22
Purine nucleoside phosphorylase deficiency 1 | 11
Renal Cell Carcinoma 1 | 199
Stomach Neoplasms 1 | 282
Urolithiasis 1 | 2
Uterine Cervical Neoplasm 1 | 21
Vitelliform macular dystrophy 1 | 14
Waldenstrons macroglobulinemia 1 | 765
Werner syndrome 1 | 29
XFE Progeroid Syndrome 1 | 1
Xanthogranulomatous pyelonephritis 1 | 4
Xeroderma Pigmentosum, Type G/Cockayne Syndrome 1 | 1
Xeroderma pigmentosum, group F 1 | 1
Xeroderma pigmentosum, group G 1 | 1
atypical teratoid / rhabdoid tumor 1 | 4,369
colon cancer 1 | 1,475
diabetes mellitus 1 | 1,663
ductal carcinoma in situ 1 | 1,745
gastric cancer 1 | 430
glioblastoma 1 | 5,572
group 3 medulloblastoma 1 | 2,254
hepatocellular carcinoma 1 | 532
intraductal papillary-mucinous adenoma (IPMA) 1 | 2,956
invasive ductal carcinoma 1 | 2,950
lung adenocarcinoma 1 | 2,713
malignant mesothelioma 1 | 3,162
non primary Sjogren syndrome sicca 1 | 840
non-small cell lung cancer 1 | 2,798
non-small cell lung carcinoma 1 | 413
pancreatic cancer 1 | 2,300
pancreatic carcinoma 1 | 567
pancreatic ductal adenocarcinoma liver metastasis 1 | 1,795
posterior fossa group B ependymoma 1 | 1,530
sonic hedgehog group medulloblastoma 1 | 1,482
subependymal giant cell astrocytoma 1 | 2,287
tuberculosis 1 | 1,557
ulcerative colitis 1 | 2,087

Tissue

Blood and immune system 5 | 17,995
Cardiovascular System 5 | 17,958
Digestive Tract 5 | 18,473
Endocrine System 5 | 18,512
Female tissues 5 | 18,647
Liver and Pancreas 5 | 18,136
Male tissues 5 | 17,969
Nervous System 5 | 18,561
Respiratory system 5 | 17,484
Skin and soft tissues 5 | 18,115
Urinary Tract 5 | 18,444

Target Family

Enzyme 4 | 4,146
Non-IDG 1 | 11,971

Grant Application

5R29ES010162-02 5 | 5
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
DNA repair protein complementing XP-G cells ERCC5 Tchem Enzyme -2.46909 296.8 215
Flap endonuclease 1 FEN1 Tchem Enzyme -2.72054 533.8 332
DNA repair endonuclease XPF ERCC4 Tbio Enzyme -2.40552 252.5 195
Adenine phosphoribosyltransferase APRT Tbio Enzyme -2.35306 222.4 220
DNA excision repair protein ERCC-1 ERCC1 Tbio Non-IDG -2.94626 969.9 606